[Transpupillary thermotherapy for subfoveal choroidal neovascularization. A 9-month follow-up]
Standard
[Transpupillary thermotherapy for subfoveal choroidal neovascularization. A 9-month follow-up]. / Feucht, M; Fuisting, Bettina; Richard, G.
in: OPHTHALMOLOGE, Jahrgang 101, Nr. 11, 11, 2004, S. 1105-1110.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Transpupillary thermotherapy for subfoveal choroidal neovascularization. A 9-month follow-up]
AU - Feucht, M
AU - Fuisting, Bettina
AU - Richard, G
PY - 2004
Y1 - 2004
N2 - PURPOSE: The purpose of this study was to evaluate the efficiency, stability, and safety of transpupillary thermotherapy as a treatment of subfoveal occult choroidal neovascularizations (CNV) in age-related macular degeneration. METHODS: Transpupillary thermotherapy (TTT) was performed in 40 patients with uni- or bilateral predominantly occult CNV. Laser light derived from an infrared diode laser at 810 nm was used to apply spots for a duration of 60 s. A complete ophthalmic examination was performed prior to and 9 months after the treatment. RESULTS: After 9 months, visual acuity remained stable in 65% (+/-2 lines). In 35% of the patients TTT could not prevent further visual loss. Retinal leakage, assessed by fluorescein angiography, stabilized in 67.5% of the treated patients. CONCLUSIONS: The present data show stabilization of visual acuity in 65% after TTT. Compared to the natural course of occult and mixed subfoveal CNV, these data give some evidence for patient benefit after TTT.
AB - PURPOSE: The purpose of this study was to evaluate the efficiency, stability, and safety of transpupillary thermotherapy as a treatment of subfoveal occult choroidal neovascularizations (CNV) in age-related macular degeneration. METHODS: Transpupillary thermotherapy (TTT) was performed in 40 patients with uni- or bilateral predominantly occult CNV. Laser light derived from an infrared diode laser at 810 nm was used to apply spots for a duration of 60 s. A complete ophthalmic examination was performed prior to and 9 months after the treatment. RESULTS: After 9 months, visual acuity remained stable in 65% (+/-2 lines). In 35% of the patients TTT could not prevent further visual loss. Retinal leakage, assessed by fluorescein angiography, stabilized in 67.5% of the treated patients. CONCLUSIONS: The present data show stabilization of visual acuity in 65% after TTT. Compared to the natural course of occult and mixed subfoveal CNV, these data give some evidence for patient benefit after TTT.
M3 - SCORING: Zeitschriftenaufsatz
VL - 101
SP - 1105
EP - 1110
JO - OPHTHALMOLOGE
JF - OPHTHALMOLOGE
SN - 0941-293X
IS - 11
M1 - 11
ER -
